List of Tables
Table 1. Global Mefenamic Acid Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Mefenamic Acid Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Mefenamic Acid Market Competitive Situation by Manufacturers in 2024
Table 4. Global Mefenamic Acid Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Mefenamic Acid Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Mefenamic Acid Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Mefenamic Acid Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Mefenamic Acid Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Mefenamic Acid, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Mefenamic Acid, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Mefenamic Acid, Product Type & Application
Table 12. Global Key Manufacturers of Mefenamic Acid, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Mefenamic Acid by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mefenamic Acid as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Mefenamic Acid Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Mefenamic Acid Sales by Region (2020-2025) & (K Units)
Table 18. Global Mefenamic Acid Sales Market Share by Region (2020-2025)
Table 19. Global Mefenamic Acid Sales by Region (2026-2031) & (K Units)
Table 20. Global Mefenamic Acid Sales Market Share by Region (2026-2031)
Table 21. Global Mefenamic Acid Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Mefenamic Acid Revenue Market Share by Region (2020-2025)
Table 23. Global Mefenamic Acid Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Mefenamic Acid Revenue Market Share by Region (2026-2031)
Table 25. North America Mefenamic Acid Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Mefenamic Acid Sales by Country (2020-2025) & (K Units)
Table 27. North America Mefenamic Acid Sales by Country (2026-2031) & (K Units)
Table 28. North America Mefenamic Acid Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Mefenamic Acid Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Mefenamic Acid Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Mefenamic Acid Sales by Country (2020-2025) & (K Units)
Table 32. Europe Mefenamic Acid Sales by Country (2026-2031) & (K Units)
Table 33. Europe Mefenamic Acid Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Mefenamic Acid Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Mefenamic Acid Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Mefenamic Acid Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Mefenamic Acid Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Mefenamic Acid Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Mefenamic Acid Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Mefenamic Acid Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Mefenamic Acid Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Mefenamic Acid Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Mefenamic Acid Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Mefenamic Acid Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Mefenamic Acid Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Mefenamic Acid Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Mefenamic Acid Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Mefenamic Acid Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Mefenamic Acid Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Mefenamic Acid Sales (K Units) by Type (2020-2025)
Table 51. Global Mefenamic Acid Sales (K Units) by Type (2026-2031)
Table 52. Global Mefenamic Acid Sales Market Share by Type (2020-2025)
Table 53. Global Mefenamic Acid Sales Market Share by Type (2026-2031)
Table 54. Global Mefenamic Acid Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Mefenamic Acid Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Mefenamic Acid Revenue Market Share by Type (2020-2025)
Table 57. Global Mefenamic Acid Revenue Market Share by Type (2026-2031)
Table 58. Global Mefenamic Acid Price (US$/Unit) by Type (2020-2025)
Table 59. Global Mefenamic Acid Price (US$/Unit) by Type (2026-2031)
Table 60. Global Mefenamic Acid Sales (K Units) by Application (2020-2025)
Table 61. Global Mefenamic Acid Sales (K Units) by Application (2026-2031)
Table 62. Global Mefenamic Acid Sales Market Share by Application (2020-2025)
Table 63. Global Mefenamic Acid Sales Market Share by Application (2026-2031)
Table 64. Global Mefenamic Acid Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Mefenamic Acid Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Mefenamic Acid Revenue Market Share by Application (2020-2025)
Table 67. Global Mefenamic Acid Revenue Market Share by Application (2026-2031)
Table 68. Global Mefenamic Acid Price (US$/Unit) by Application (2020-2025)
Table 69. Global Mefenamic Acid Price (US$/Unit) by Application (2026-2031)
Table 70. Shionogi Pharma Company Information
Table 71. Shionogi Pharma Description and Business Overview
Table 72. Shionogi Pharma Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Shionogi Pharma Mefenamic Acid Product
Table 74. Shionogi Pharma Recent Developments/Updates
Table 75. Solitaire Pharmacia Company Information
Table 76. Solitaire Pharmacia Description and Business Overview
Table 77. Solitaire Pharmacia Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Solitaire Pharmacia Mefenamic Acid Product
Table 79. Solitaire Pharmacia Recent Developments/Updates
Table 80. Shinto Organics Company Information
Table 81. Shinto Organics Description and Business Overview
Table 82. Shinto Organics Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Shinto Organics Mefenamic Acid Product
Table 84. Shinto Organics Recent Developments/Updates
Table 85. Captab Company Information
Table 86. Captab Description and Business Overview
Table 87. Captab Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Captab Mefenamic Acid Product
Table 89. Captab Recent Developments/Updates
Table 90. EMS Pharma Company Information
Table 91. EMS Pharma Description and Business Overview
Table 92. EMS Pharma Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. EMS Pharma Mefenamic Acid Product
Table 94. EMS Pharma Recent Developments/Updates
Table 95. Adelco Company Information
Table 96. Adelco Description and Business Overview
Table 97. Adelco Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Adelco Mefenamic Acid Product
Table 99. Adelco Recent Developments/Updates
Table 100. Agron Remedies Company Information
Table 101. Agron Remedies Description and Business Overview
Table 102. Agron Remedies Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Agron Remedies Mefenamic Acid Product
Table 104. Agron Remedies Recent Developments/Updates
Table 105. IASIS Pharmaceuticals Hellas Company Information
Table 106. IASIS Pharmaceuticals Hellas Description and Business Overview
Table 107. IASIS Pharmaceuticals Hellas Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. IASIS Pharmaceuticals Hellas Mefenamic Acid Product
Table 109. IASIS Pharmaceuticals Hellas Recent Developments/Updates
Table 110. ABL Lifecare Company Information
Table 111. ABL Lifecare Description and Business Overview
Table 112. ABL Lifecare Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. ABL Lifecare Mefenamic Acid Product
Table 114. ABL Lifecare Recent Developments/Updates
Table 115. Farmo Quimica Company Information
Table 116. Farmo Quimica Description and Business Overview
Table 117. Farmo Quimica Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Farmo Quimica Mefenamic Acid Product
Table 119. Farmo Quimica Recent Developments/Updates
Table 120. Apotex Company Information
Table 121. Apotex Description and Business Overview
Table 122. Apotex Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Apotex Mefenamic Acid Product
Table 124. Apotex Recent Developments/Updates
Table 125. Sanofi Aventis Company Information
Table 126. Sanofi Aventis Description and Business Overview
Table 127. Sanofi Aventis Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Sanofi Aventis Mefenamic Acid Product
Table 129. Sanofi Aventis Recent Developments/Updates
Table 130. Yung Sine Company Information
Table 131. Yung Sine Description and Business Overview
Table 132. Yung Sine Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Yung Sine Mefenamic Acid Product
Table 134. Yung Sine Recent Developments/Updates
Table 135. Streuli Pharma, Company Information
Table 136. Streuli Pharma, Description and Business Overview
Table 137. Streuli Pharma, Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Streuli Pharma, Mefenamic Acid Product
Table 139. Streuli Pharma, Recent Developments/Updates
Table 140. Mankind Company Information
Table 141. Mankind Description and Business Overview
Table 142. Mankind Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Mankind Mefenamic Acid Product
Table 144. Mankind Recent Developments/Updates
Table 145. Pfizer Company Information
Table 146. Pfizer Description and Business Overview
Table 147. Pfizer Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Pfizer Mefenamic Acid Product
Table 149. Pfizer Recent Developments/Updates
Table 150. Daiichi Sankyo Company Information
Table 151. Daiichi Sankyo Description and Business Overview
Table 152. Daiichi Sankyo Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Daiichi Sankyo Mefenamic Acid Product
Table 154. Daiichi Sankyo Recent Developments/Updates
Table 155. Chemidex Pharma Company Information
Table 156. Chemidex Pharma Description and Business Overview
Table 157. Chemidex Pharma Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 158. Chemidex Pharma Mefenamic Acid Product
Table 159. Chemidex Pharma Recent Developments/Updates
Table 160. AA Pharma Company Information
Table 161. AA Pharma Description and Business Overview
Table 162. AA Pharma Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 163. AA Pharma Mefenamic Acid Product
Table 164. AA Pharma Recent Developments/Updates
Table 165. Nisshin Pharmaceutical Company Information
Table 166. Nisshin Pharmaceutical Description and Business Overview
Table 167. Nisshin Pharmaceutical Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 168. Nisshin Pharmaceutical Mefenamic Acid Product
Table 169. Nisshin Pharmaceutical Recent Developments/Updates
Table 170. Koa Isei Company Information
Table 171. Koa Isei Description and Business Overview
Table 172. Koa Isei Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 173. Koa Isei Mefenamic Acid Product
Table 174. Koa Isei Recent Developments/Updates
Table 175. Teva Company Information
Table 176. Teva Description and Business Overview
Table 177. Teva Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 178. Teva Mefenamic Acid Product
Table 179. Teva Recent Developments/Updates
Table 180. Wockhardt Company Information
Table 181. Wockhardt Description and Business Overview
Table 182. Wockhardt Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 183. Wockhardt Mefenamic Acid Product
Table 184. Wockhardt Recent Developments/Updates
Table 185. Esteve Company Information
Table 186. Esteve Description and Business Overview
Table 187. Esteve Mefenamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 188. Esteve Mefenamic Acid Product
Table 189. Esteve Recent Developments/Updates
Table 190. Key Raw Materials Lists
Table 191. Raw Materials Key Suppliers Lists
Table 192. Mefenamic Acid Distributors List
Table 193. Mefenamic Acid Customers List
Table 194. Mefenamic Acid Market Trends
Table 195. Mefenamic Acid Market Drivers
Table 196. Mefenamic Acid Market Challenges
Table 197. Mefenamic Acid Market Restraints
Table 198. Research Programs/Design for This Report
Table 199. Key Data Information from Secondary Sources
Table 200. Key Data Information from Primary Sources
Table 201. Authors List of This Report
List of Figures
Figure 1. Product Picture of Mefenamic Acid
Figure 2. Global Mefenamic Acid Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Mefenamic Acid Market Share by Type: 2024 & 2031
Figure 4. Patent Product Picture
Figure 5. Generic Product Picture
Figure 6. Global Mefenamic Acid Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Mefenamic Acid Market Share by Application: 2024 & 2031
Figure 8. Hospital
Figure 9. Drug Store
Figure 10. On-line
Figure 11. Global Mefenamic Acid Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Mefenamic Acid Market Size (2020-2031) & (US$ Million)
Figure 13. Global Mefenamic Acid Sales (2020-2031) & (K Units)
Figure 14. Global Mefenamic Acid Average Price (US$/Unit) & (2020-2031)
Figure 15. Mefenamic Acid Report Years Considered
Figure 16. Mefenamic Acid Sales Share by Manufacturers in 2024
Figure 17. Global Mefenamic Acid Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Mefenamic Acid Players: Market Share by Revenue in Mefenamic Acid in 2024
Figure 19. Mefenamic Acid Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Mefenamic Acid Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Mefenamic Acid Sales Market Share by Country (2020-2031)
Figure 22. North America Mefenamic Acid Revenue Market Share by Country (2020-2031)
Figure 23. United States Mefenamic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Mefenamic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Mefenamic Acid Sales Market Share by Country (2020-2031)
Figure 26. Europe Mefenamic Acid Revenue Market Share by Country (2020-2031)
Figure 27. Germany Mefenamic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Mefenamic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Mefenamic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Mefenamic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Mefenamic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Mefenamic Acid Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Mefenamic Acid Revenue Market Share by Region (2020-2031)
Figure 34. China Mefenamic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Mefenamic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Mefenamic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Mefenamic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Mefenamic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Mefenamic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Mefenamic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Mefenamic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Mefenamic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Mefenamic Acid Sales Market Share by Country (2020-2031)
Figure 44. Latin America Mefenamic Acid Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Mefenamic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Mefenamic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Mefenamic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Mefenamic Acid Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Mefenamic Acid Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Mefenamic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Mefenamic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Mefenamic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Mefenamic Acid by Type (2020-2031)
Figure 54. Global Revenue Market Share of Mefenamic Acid by Type (2020-2031)
Figure 55. Global Mefenamic Acid Price (US$/Unit) by Type (2020-2031)
Figure 56. Global Sales Market Share of Mefenamic Acid by Application (2020-2031)
Figure 57. Global Revenue Market Share of Mefenamic Acid by Application (2020-2031)
Figure 58. Global Mefenamic Acid Price (US$/Unit) by Application (2020-2031)
Figure 59. Mefenamic Acid Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed